-
2
-
-
0037902480
-
T cell anergy and costimulation
-
DOI 10.1034/j.1600-065X.2003.00009.x
-
Appleman LJ, Boussiotis VA. T cell anergy and costimulation. Immunol Rev 2003; 192:161-80. (Pubitemid 36613331)
-
(2003)
Immunological Reviews
, vol.192
, pp. 161-180
-
-
Appleman, L.J.1
Boussiotis, V.A.2
-
3
-
-
34548774646
-
Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse
-
Bour-Jordan H, Salomon BL, Thompson HL, Santos R, Abbas AK, Bluestone JA. Constitutive expression of B7-1 on B cells uncovers autoimmunity toward the B cell compartment in the nonobese diabetic mouse. J Immunol 2007; 179:1004-12.
-
(2007)
J Immunol
, vol.179
, pp. 1004-1012
-
-
Bour-Jordan, H.1
Salomon, B.L.2
Thompson, H.L.3
Santos, R.4
Abbas, A.K.5
Bluestone, J.A.6
-
4
-
-
34447521710
-
CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE
-
DOI 10.1002/eji.200636971
-
Yang Y, Ratts RB, Hussain RZ, Northrop SC, Ben LH, Lovett-Racke A, Racke MK. CD28:B7 interaction is necessary for the protective effect of T cell vaccination in EAE. Eur J Immunol 2007; 37:2032-42. (Pubitemid 47065138)
-
(2007)
European Journal of Immunology
, vol.37
, Issue.7
, pp. 2032-2042
-
-
Yang, Y.1
Ratts, R.B.2
Hussain, R.Z.3
Northrop, S.C.4
Ben, L.-H.5
Lovett-Racke, A.6
Racke, M.K.7
-
5
-
-
0037446656
-
B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis
-
Poussin MA, Tüzün E, Goluszko E, Scott BG, Yang H, Franco JU, Christadoss P. B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis. J Immunol 2003; 170:4389-96. (Pubitemid 36428209)
-
(2003)
Journal of Immunology
, vol.170
, Issue.8
, pp. 4389-4396
-
-
Poussin, M.A.1
Tuzun, E.2
Goluszko, E.3
Scott, B.G.4
Yang, H.5
Franco, J.U.6
Christadoss, P.7
-
6
-
-
59949099339
-
Urinary CD80 excretion increases in idiopathic minimal-change disease
-
Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, Johnson RJ. Urinary CD80 excretion increases in idiopathic minimal-change disease. J Am Soc Nephrol 2009; 20:260-6.
-
(2009)
J Am Soc Nephrol
, vol.20
, pp. 260-266
-
-
Garin, E.H.1
Diaz, L.N.2
Mu, W.3
Wasserfall, C.4
Araya, C.5
Segal, M.6
Johnson, R.J.7
-
7
-
-
69949148701
-
Blocking T cell co-stimulation using a CD80 blocking small molecule reduces delayed type hypersensitivity responses in rhesus monkeys
-
Haanstra KG, Endell J, Estévâo D, Kondova I, Jonker M. Blocking T cell co-stimulation using a CD80 blocking small molecule reduces delayed type hypersensitivity responses in rhesus monkeys. Clin Exp Immunol 2009; 158:91-8.
-
(2009)
Clin Exp Immunol
, vol.158
, pp. 91-98
-
-
Haanstra, K.G.1
Endell, J.2
Estévâo, D.3
Kondova, I.4
Jonker, M.5
-
8
-
-
0018953062
-
Production of monoclonal antibodies: Strategy and tactics
-
DOI 10.1016/0022-1759(80)90146-5
-
Groth SF, Scheidegger D. Production of monoclonal antibodies: strategy tactics. J Immunol Methods 1980; 35:1-21. (Pubitemid 10034772)
-
(1980)
Journal of Immunological Methods
, vol.35
, Issue.1-2
, pp. 1-21
-
-
Groth, S.F.1
Scheidegger, D.2
-
9
-
-
33646087182
-
Characterization and application of two novel monoclonal antibodies against human OX40: Costimulation of T cells and expression on tumor as well as normal gland tissues
-
Xie F, Wang Q, Chen Y, et al. Characterization and application of two novel monoclonal antibodies against human OX40: costimulation of T cells and expression on tumor as well as normal gland tissues. Tissue Antigens 2006; 67:307-17.
-
(2006)
Tissue Antigens
, vol.67
, pp. 307-317
-
-
Xie, F.1
Wang, Q.2
Chen, Y.3
-
10
-
-
2342436250
-
Distinctive patterns of autoimmune response induced by different types of mineral oil
-
DOI 10.1093/toxsci/kfh063
-
Kuroda Y, Akaogi J, Nacionales DC, Wasdo SC, Szabo NJ, Reeves WH, Satoh MD. Instinctive patterns of autoimmune response induced by different types of mineral oil. Toxicol Sci 2004; 78:222-28. (Pubitemid 38559670)
-
(2004)
Toxicological Sciences
, vol.78
, Issue.2
, pp. 222-228
-
-
Kuroda, Y.1
Akaogi, J.2
Nacionales, D.C.3
Wasdo, S.C.4
Szabo, N.J.5
Reeves, W.H.6
Satoh, M.7
-
11
-
-
38849162227
-
Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies
-
Frisoni L, McPhie L, Kang SA, Monestier M, Madaio M, Satoh M, Caricchio R. Lack of chromatin and nuclear fragmentation in vivo impairs the production of lupus anti-nuclear antibodies. J Immunol 2007; 179:7959-66.
-
(2007)
J Immunol
, vol.179
, pp. 7959-7966
-
-
Frisoni, L.1
McPhie, L.2
Kang, S.A.3
Monestier, M.4
Madaio, M.5
Satoh, M.6
Caricchio, R.7
-
12
-
-
0033577903
-
A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus
-
Chan OT, Hannum LG, Haberman AM, Madaio MP, Shlomchik MJ. A novel mouse with B cells but lacking serum antibody reveals an antibody-independent role for B cells in murine lupus. J Exp Med 1999; 189:1639-48.
-
(1999)
J Exp Med
, vol.189
, pp. 1639-1648
-
-
Chan, O.T.1
Hannum, L.G.2
Haberman, A.M.3
Madaio, M.P.4
Shlomchik, M.J.5
-
13
-
-
0033214474
-
B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity
-
Chan OT, Madaio MP, Shlomchik M. B cells are required for lupus nephritis in the polygenic: Fas-intact MRL model of systemic autoimmunity. J Immunol 1997; 163:3592-96. (Pubitemid 29450878)
-
(1999)
Journal of Immunology
, vol.163
, Issue.7
, pp. 3592-3596
-
-
Chan, O.T.M.1
Madaio, M.P.2
Shlomchik, M.J.3
-
14
-
-
0032931973
-
Costimulatory regulation of T cell function
-
DOI 10.1016/S0955-0674(99)80027-1
-
Chambers CA, Allison JP. Costimulatory regulation of T cell function. Curr Opin Cell Biol 1999; 11:203-10. (Pubitemid 29164035)
-
(1999)
Current Opinion in Cell Biology
, vol.11
, Issue.2
, pp. 203-210
-
-
Chambers, C.A.1
Allison, J.P.2
-
15
-
-
77349107166
-
Receptor and ligands implicated in hunman T cell costimulatory process
-
Judith L, Katharina GP, Peter S. Receptor and ligands implicated in hunman T cell costimulatory process. Immunol Lett 2010; 128:89-89.
-
(2010)
Immunol Lett
, vol.128
, pp. 89-89
-
-
Judith, L.1
Katharina, G.P.2
Peter, S.3
-
16
-
-
0038491416
-
+ T cells independent of the PD-1 receptor
-
DOI 10.1084/jem.20030242
-
Shin T, Kennedy G, Gorski K, et al. Cooperative B7-1/2(CD80/CD86) and B7-DC costimulation of CD4+ T Cells independent of the PD-1 receptor. J Exp Med 2003; 198:31-8. (Pubitemid 36870183)
-
(2003)
Journal of Experimental Medicine
, vol.198
, Issue.1
, pp. 31-38
-
-
Shin, T.1
Kennedy, G.2
Gorski, K.3
Tsuchiya, H.4
Koseki, H.5
Azuma, M.6
Yagita, H.7
Chen, L.8
Powell, J.9
Pardoll, D.10
Housseau, F.11
-
17
-
-
46749114315
-
Interaction of human PD-L1 and B7-1
-
Butte MJ, Peña-Cruz V, Kim MJ, Freeman GJ, Sharpe AH. Interaction of human PD-L1 and B7-1. Molec Immunol 2008; 45:3567-72.
-
(2008)
Molec Immunol
, vol.45
, pp. 3567-3572
-
-
Butte, M.J.1
Peña-Cruz, V.2
Kim, M.J.3
Freeman, G.J.4
Sharpe, A.H.5
-
18
-
-
15944368279
-
Block and tackle: CTLA4Ig takes on lupus
-
DOI 10.1191/0961203305lu2136oa
-
Davidson A, Diamond B, Wofsy D, Daikh D. Block and tackle: CTLA4Ig takes on lupus. Lupus 2005; 14:197-203. (Pubitemid 40445583)
-
(2005)
Lupus
, vol.14
, Issue.3
, pp. 197-203
-
-
Davidson, A.1
Diamond, B.2
Wofsy, D.3
Daikh, D.4
-
19
-
-
77952523821
-
Biologic therapy for systemic lupus erythematosus
-
Dall'Era M, Wofsy D. Biologic therapy for systemic lupus erythematosus. Discov Med 2010; 9:20-3.
-
(2010)
Discov Med
, vol.9
, pp. 20-23
-
-
Dall'Era, M.1
Wofsy, D.2
-
20
-
-
33846233931
-
Inhibiting costimulatory activation of T cells: A viable treatment option for rheumatoid arthritis?
-
DOI 10.2165/00003495-200767010-00001
-
Pollard LC. Inhibiting costimulatory activation of T cells: a viable treatment option for rheumatoid arthritis? Drugs 2007; 67:1-9. (Pubitemid 46105083)
-
(2007)
Drugs
, vol.67
, Issue.1
, pp. 1-9
-
-
Pollard, L.C.1
-
21
-
-
34249292281
-
Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice
-
DOI 10.1111/j.1365-2567.2007.02581.x
-
Asai T, Choi BK, Kwon PM, Kim WY, Kim JD, Vinay DS, Gebhardt BM, Kwon BS. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice. Immunology 2007; 121:349-58. (Pubitemid 46817356)
-
(2007)
Immunology
, vol.121
, Issue.3
, pp. 349-358
-
-
Asai, T.1
Choi, B.K.2
Kwon, P.M.3
Kim, W.Y.4
Kim, J.D.5
Vinay, D.S.6
Gebhardt, B.M.7
Kwon, B.S.8
-
22
-
-
65349188127
-
Translating costimulation blockade to the clinic: Lessons learned from three pathways
-
Ford ML, Larsen CP. Translating costimulation blockade to the clinic: lessons learned from three pathways. Immunol Rev 2009; 229:294-306.
-
(2009)
Immunol Rev
, vol.229
, pp. 294-306
-
-
Ford, M.L.1
Larsen, C.P.2
-
23
-
-
33745145869
-
Chowdhury, Tsokos GC. Autoimmunity in systemic lupus erythematosus: Integrating genes and biology
-
Krishnan SB, Chowdhury, Tsokos GC. Autoimmunity in systemic lupus erythematosus: integrating genes and biology. Semin Immunol 2006; 18:230-43.
-
(2006)
Semin Immunol
, vol.18
, pp. 230-243
-
-
Krishnan, S.B.1
-
24
-
-
0032893728
-
Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus
-
Liu MF, Li JS, Weng TH, Lei HY. Differential expression and modulation of costimulatory molecules CD80 and CD86 on monocytes from patients with systemic lupus erythematosus. Scand J Immunol 1999; 49:82-7.
-
(1999)
Scand J Immunol
, vol.49
, pp. 82-87
-
-
Liu, M.F.1
Li, J.S.2
Weng, T.H.3
Lei, H.Y.4
-
25
-
-
24944465752
-
Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus
-
DOI 10.1093/rheumatology/keh663
-
Wong CK, Lit LC, Tam LS, Li EK, Lam CW. Abenant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2005; 44:989-94. (Pubitemid 41487170)
-
(2005)
Rheumatology
, vol.44
, Issue.8
, pp. 989-994
-
-
Wong, C.K.1
Lit, L.C.W.2
Tam, L.S.3
Li, E.K.4
Lam, C.W.K.5
-
26
-
-
0033072131
-
The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: Implication for immunotherapy
-
Takasaki Y, Abe K, Tokano Y, Hashimoto H. The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in lupus patients: implication for immunotherapy. Intern Med 1999; 38:175-77.
-
(1999)
Intern Med
, vol.38
, pp. 175-177
-
-
Takasaki, Y.1
Abe, K.2
Tokano, Y.3
Hashimoto, H.4
-
27
-
-
0032935966
-
Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus
-
Abe K, Takasaki Y, Ushiyama C, Asakawa J, Fukazawa T, Seki M, Hirashima M, Ogaki M, Hashimoto H. Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus. Clin Immunol 1999; 19:58-66. (Pubitemid 29113333)
-
(1999)
Journal of Clinical Immunology
, vol.19
, Issue.1
, pp. 58-66
-
-
Abe, K.1
Takasaki, Y.2
Ushiyama, C.3
Asakawa, J.4
Fukazawa, T.5
Seki, M.6
Hirashima, M.7
Ogaki, M.8
Hashimoto, H.9
-
28
-
-
0030904858
-
In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus
-
Denfeld RW, Kind P, Sontheimer RD, Schöpf E, Simon JC. In situ expression of B7 and CD28 receptor families in skin lesions of patients with lupus erythematosus. Arthritis Rheum 1997; 40:814-21. (Pubitemid 27199996)
-
(1997)
Arthritis and Rheumatism
, vol.40
, Issue.5
, pp. 814-821
-
-
Denfeld, R.W.1
Kind, P.2
Sontheimer, R.D.3
Schopf, E.4
Simon, J.C.5
-
29
-
-
0034041205
-
Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Fas(lpr) mice
-
Kinoshita K, Tesch G, Schwarting A, Maron R, Sharpe AH, Kelley VR. Costimulation by B7-1 and B7-2 is required for autoimmune disease in MRL-Fas1pr mice. J Immunol 2000; 164:6046-56. (Pubitemid 30389855)
-
(2000)
Journal of Immunology
, vol.164
, Issue.11
, pp. 6046-6056
-
-
Kinoshita, K.1
Tesch, G.2
Schwarting, A.3
Maron, R.4
Sharpe, A.H.5
Kelley, V.R.6
-
30
-
-
6344275147
-
Costimulation requirements of induced murine systemic autoimmune disease
-
Pollard KM, Arnush M, Hultman P, Kono DH. Costimulation requirements of induced murine systemic autoimmune disease.J Immunol 2004; 173:5880-7. (Pubitemid 39392179)
-
(2004)
Journal of Immunology
, vol.173
, Issue.9
, pp. 5880-5887
-
-
Pollard, K.M.1
Arnush, M.2
Hultman, P.3
Kono, D.H.4
-
31
-
-
0025873393
-
Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7
-
Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, Fingeroth JD, Gribben JG, Nadler LM. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med 1991; 174:625-31.
-
(1991)
J Exp Med
, vol.174
, pp. 625-631
-
-
Freeman, G.J.1
Gray, G.S.2
Gimmi, C.D.3
Lombard, D.B.4
Zhou, L.J.5
White, M.6
Fingeroth, J.D.7
Gribben, J.G.8
Nadler, L.M.9
-
32
-
-
0027938860
-
Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane
-
DOI 10.1084/jem.180.6.2341
-
Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994; 180:2341-6. (Pubitemid 24351616)
-
(1994)
Journal of Experimental Medicine
, vol.180
, Issue.6
, pp. 2341-2346
-
-
Satoh, M.1
Reeves, W.H.2
-
33
-
-
0028845353
-
Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane
-
Satoh M, Kumar A, Kanwar YS, Reeves WH. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc Natl Acad Sci 1995; 92:10934-38.
-
(1995)
Proc Natl Acad Sci
, vol.92
, pp. 10934-10938
-
-
Satoh, M.1
Kumar, A.2
Kanwar, Y.S.3
Reeves, W.H.4
-
34
-
-
33645455804
-
Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl-pentadecane (pristane)
-
Nacionales DC, Kelly KM, Lee PY, et al. Type I interferon production by tertiary lymphoid tissue developing in response to 2,6,10,14-tetramethyl- pentadecane (pristane). Am J Pathol 2006; 168:1227-40.
-
(2006)
Am J Pathol
, vol.168
, pp. 1227-1240
-
-
Nacionales, D.C.1
Kelly, K.M.2
Lee, P.Y.3
-
35
-
-
54049138278
-
B-cell-directed therapies in systemic lupus erythematosus
-
Arlene TT, Elena P. B-cell-directed therapies in systemic lupus erythematosus. S Arthritis Rheum 2008; 38:218-27.
-
(2008)
S Arthritis Rheum
, vol.38
, pp. 218-227
-
-
Arlene, T.T.1
Elena, P.2
-
36
-
-
77956844800
-
Therapeutic strategies for SLE involving cytokines: Mechanism-oriented therapies especially IFN-gamma targeting gene therapy
-
Hayashi T. Therapeutic strategies for SLE involving cytokines: mechanism-oriented therapies especially IFN-gamma targeting gene therapy. J Biomed Biotechnol 2010; 2010:1-19.
-
(2010)
J Biomed Biotechnol
, vol.2010
, pp. 1-19
-
-
Hayashi, T.1
-
37
-
-
79952481036
-
Targeting B cells for the treatment of SLE: The beginning of the end or the end of the beginning?
-
Calero I, Sanz I. Targeting B cells for the treatment of SLE: the beginning of the end or the end of the beginning? Discov Med 2010; 10:416-24.
-
(2010)
Discov Med
, vol.10
, pp. 416-424
-
-
Calero, I.1
Sanz, I.2
-
38
-
-
78449260112
-
CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: Kidney
-
Zhang JL, Sun DJ, Hou CM, et al. CD3 mAb treatment ameliorated the severity of the cGVHD-induced lupus nephritis in mice by up-regulation of Foxp3+ regulatory T cells in the target tissue: kidney Transpl Immunol 2010; 24:17-25.
-
(2010)
Transpl Immunol
, vol.24
, pp. 17-25
-
-
Zhang, J.L.1
Sun, D.J.2
Hou, C.M.3
|